GMT (Omicron) of anti-SARS-CoV-2 neutralizing antibody in adults ≥18 years of age;the 4-fold rise rate of anti-omicron neutralizing antibody in adults ≥18 years of age;The incidence of AESI observed;The incidence of SAE observed;The incidence rate of any adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence severity of any adverse reactions/events;The incidence severity of solicited adverse reactions/events;The incidence severity of solicited adverse reactions/events

GMT (Omicron) of anti-SARS-CoV-2 neutralizing antibody in adults ≥18 years of age;the 4-fold rise rate of anti-omicron neutralizing antibody in adults ≥18 years of age;The incidence of AESI observed;The incidence of SAE observed;The incidence rate of any adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence severity of any adverse reactions/events;The incidence severity of solicited adverse reactions/events;The incidence severity of solicited adverse reactions/events

GMT (Omicron) of anti-SARS-CoV-2 neutralizing antibody;The incidence rate of any adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence severity of any adverse reactions/events;The incidence severity of solicited adverse reactions/events;The incidence severity of solicited adverse reactions/events

GMT (Omicron) of anti-SARS-CoV-2 neutralizing antibody;The incidence rate of any adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence severity of any adverse reactions/events;The incidence severity of solicited adverse reactions/events;The incidence severity of solicited adverse reactions/events